Navigation Links
Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports
Date:12/19/2007

NEW YORK (Dec. 19, 2007) -- Two deadly and highly infectious viruses -- both potential bioterror threats -- may have met their match in a new drug developed by scientists at Weill Cornell Medical College in New York City.

Hendra and Nipah viruses are related, newly recognized zoonotic viruses that can spread from their natural reservoir in fruit bats to larger animals -- including pigs, horses and humans.

The mode of transmission isn't clear, but is thought to be relatively easy -- either by close contact with an infected host or by breathing in the microscopic pathogens. Infection often leads to a fatal encephalitis, and there is currently no effective treatment against these illnesses.

However, in breakthrough research conducted last year, researchers at Weill Cornell manipulated a peptide (protein) related to a third pathogen, parainfluenza virus, that appeared to block "pseudo" Hendra and Nipah viruses from entering and infecting human cells.

Now, this "entry inhibitor" approach has proven effective in blocking the infection of live virus in animal cells, pointing the way to a drug that could be stockpiled to help stop an outbreak in humans.

Those findings appeared recently in the Journal of Virology.

"We have now tested the peptide-based entry inhibitor in monkey cells to show that it does effectively block infection with both live Hendra and Nipah," explains study senior researcher Dr. Anne Moscona, a professor of pediatrics and of microbiology and immunology at Weill Cornell Medical College, and an attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Public health officials have sounded alarm bells ever since Nipah virus first emerged in pigs and then humans living in Southeast Asia. More recently, cases of Hendra virus began to show up in horses and their human handlers in Australia.

Experts who drew up the U.S. National Institute of Allergy and Infe
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Using evolution, UW team creates a template for many new therapeutic agents
2. Primate behavior explained by computer agents
3. Building blocks of life
4. Natural product discovery by Cleveland medical researchers blocks tissue destruction
5. Scripps research team blocks bacterial communication system to prevent deadly staph infections
6. Building blocks of life formed on Mars
7. Clearance of hepatitis C viral infection after liver transplantation
8. Feline virus, antiviral drug studied to understand drug resistance
9. Cornell will host the Northeast Biofuel Summit, Nov. 11-13
10. First symposium of UN University-Cornell Africa Series to be held at UN
11. Wiggle room: Cornell researcher borrows idea from sperm to provide energy for nanoscale robots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... exceptional ability to spray venom into eyes of potential ... Biochemical Zoology reveals how these snakes maximize their ... cobra" is a bit of a misnomer. Cobras don,t ... Young, director of the Anatomical Laboratory in the Department ...
... LAFAYETTE, Ind. - Researchers have created a precise ... other biological molecules by using hollow structures called ... The device resembles a tiny cube-shaped tetherball. Each ... electronic circuitry by a nanotube, which acts as ...
... the petroleum-based economy in the US is getting close ... and new petroleum discoveries will not be enough to ... to anticipate and avoid any shortfall in future supply ... the marketplace. In the context of a strong ...
Cached Biology News:Here's venom in your eye: Spitting cobras hit their mark 2Nano-tetherball biosensor precisely detects glucose 2Nano-tetherball biosensor precisely detects glucose 3Nano-tetherball biosensor precisely detects glucose 4
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... Miami, FL (PRWEB) May 21, 2013 ... and breakouts as contributor to acne. Recently physicians from ... effects of mental stress on the skin, and suggested ... to help reduce the chemicals produced from stress that ... aside from the negative feelings acne brings about, stress ...
(Date:5/21/2013)...  MacroGenics, Inc. today announced that an abstract ... Fc-modified chimeric monoclonal antibody (MAb), in patients with ... be presented at the 2013 Annual Meeting of ... Developmental Therapeutics - Immunotherapy Oral Abstract Session on ... The presentation will describe the results of a ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... Clients in Kentucky, Indiana,Tennessee, Georgia, Alabama, Ohio and ... Nikon Instruments Inc.,announced that it has appointed Laboratory ... Indiana, Tennessee, Georgia,Alabama, Ohio and West Virginia. LABSCO, ... in the United States, will sell,Nikon,s market leading ...
... 20 Glycotex, Inc. today announced,enrollment of the ... the effect,of GLYC-101 on wound closure and cosmetic ... skin resurfacing on the lower,eyelid area., A ... and,safety parameters of GLYC-101 at two doses compared ...
... Pharmaceuticals,Inc., a privately-held biotechnology company focused on ... diseases, announced today the,opening of its new ... Island., With support from the Rhode ... programs, Rhode Island Industrial Facilities,Corporation (RIIFC) and ...
Cached Biology Technology:Nikon Instruments Appoints LABSCO its Clinical Distributor in Six States 2Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing 2Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing 3Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 2Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 3Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 4
... single-step staining method for labeling DNA breaks ... The kit contains all the key reagents ... positive and negative control cells for assessing ... for processing individual steps in the assay; ...
... Sytem is a highly advanced digital ... digital imaging and automation technology that ... analysis, archving/retrieval and colored professional reporting. ... industry's fastest scanning and detection modules ...
... with temperature probe, 100-120 and 220-240 V, supports ... and 400 W. The temperature probe is used ... degrees C during electrophoresis. Built-in infrared capability allows ... are provided. Dimensions are 27.5 x 34 x ...
... The Model 111 mini IEF cell is ... focusing (IEF) using polyacrylamide or agarose slab ... and lid, graphite electrodes, casting tray, 5 ... film for polyacrylamide, 5 sample templates, and ...
Biology Products: